Literature DB >> 21115485

RBX1 (RING box protein 1) E3 ubiquitin ligase is required for genomic integrity by modulating DNA replication licensing proteins.

Lijun Jia1, Jeremy S Bickel, Jiaxue Wu, Meredith A Morgan, Hua Li, Jie Yang, Xiaochun Yu, Raymond C Chan, Yi Sun.   

Abstract

RBX1 (RING box protein 1), also known as ROC1 (Regulator of Cullin 1), is an essential component of SCF (Skp1/Cullins/F-box) E3 ubiquitin ligases, which target diverse proteins for proteasome-mediated degradation. Our recent study showed that RBX1 silencing triggered a DNA damage response (DDR) leading to G(2)-M arrest, senescence, and apoptosis, with the mechanism remaining elusive. Here, we show that, in human cancer cells, RBX1 silencing causes the accumulation of DNA replication licensing proteins CDT1 and ORC1, leading to DNA double-strand breaks, DDR, G(2) arrest, and, eventually, aneuploidy. Whereas CHK1 activation by RBX1 silencing is responsible for the G(2) arrest, enhanced DNA damage renders cancer cells more sensitive to radiation. In Caenorhabditis elegans, RBX-1 silencing causes CDT-1 accumulation, triggering DDR in intestinal cells, which is largely abrogated by simultaneous CDT-1 silencing. RBX-1 silencing also induces lethality during development of embryos and in adulthood. Thus, RBX1 E3 ligase is essential for the maintenance of mammalian genome integrity and the proper development and viability in C. elegans.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115485      PMCID: PMC3030344          DOI: 10.1074/jbc.M110.188425

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

Review 1.  Ubiquitin ligases: cell-cycle control and cancer.

Authors:  Keiichi I Nakayama; Keiko Nakayama
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

2.  ATPase-dependent cooperative binding of ORC and Cdc6 to origin DNA.

Authors:  Christian Speck; Zhiqiang Chen; Huilin Li; Bruce Stillman
Journal:  Nat Struct Mol Biol       Date:  2005-11       Impact factor: 15.369

3.  Chaotic license for genetic instability and cancer.

Authors:  Anindya Dutta
Journal:  Nat Genet       Date:  2007-01       Impact factor: 38.330

4.  A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1.

Authors:  Jianping Jin; Emily E Arias; Jing Chen; J Wade Harper; Johannes C Walter
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

5.  Two E3 ubiquitin ligases, SCF-Skp2 and DDB1-Cul4, target human Cdt1 for proteolysis.

Authors:  Hideo Nishitani; Nozomi Sugimoto; Vassilis Roukos; Yohsuke Nakanishi; Masafumi Saijo; Chikashi Obuse; Toshiki Tsurimoto; Keiichi I Nakayama; Keiko Nakayama; Masatoshi Fujita; Zoi Lygerou; Takeharu Nishimoto
Journal:  EMBO J       Date:  2006-02-16       Impact factor: 11.598

Review 6.  Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells.

Authors:  Emily E Arias; Johannes C Walter
Journal:  Genes Dev       Date:  2007-03-01       Impact factor: 11.361

Review 7.  Drug discovery in the ubiquitin-proteasome system.

Authors:  Grzegorz Nalepa; Mark Rolfe; J Wade Harper
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

Review 8.  Function and regulation of cullin-RING ubiquitin ligases.

Authors:  Matthew D Petroski; Raymond J Deshaies
Journal:  Nat Rev Mol Cell Biol       Date:  2005-01       Impact factor: 94.444

9.  Deregulated overexpression of hCdt1 and hCdc6 promotes malignant behavior.

Authors:  Michalis Liontos; Marilena Koutsami; Maria Sideridou; Konstantinos Evangelou; Dimitris Kletsas; Brynn Levy; Athanassios Kotsinas; Odelia Nahum; Vassilis Zoumpourlis; Mirsini Kouloukoussa; Zoi Lygerou; Stavros Taraviras; Christos Kittas; Jirina Bartkova; Athanasios G Papavassiliou; Jiri Bartek; Thanos D Halazonetis; Vassilis G Gorgoulis
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

Review 10.  DNA damage signalling guards against activated oncogenes and tumour progression.

Authors:  J Bartek; J Bartkova; J Lukas
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

View more
  31 in total

1.  Radiosensitization of human pancreatic cancer cells by MLN4924, an investigational NEDD8-activating enzyme inhibitor.

Authors:  Dongping Wei; Hua Li; Jie Yu; Jonathan T Sebolt; Lili Zhao; Theodore S Lawrence; Peter G Smith; Meredith A Morgan; Yi Sun
Journal:  Cancer Res       Date:  2011-11-09       Impact factor: 12.701

2.  Induction of cell senescence by targeting to Cullin-RING Ligases (CRLs) for effective cancer therapy.

Authors:  Yongfu Pan; Hua Xu; Rujiao Liu; Lijun Jia
Journal:  Int J Biochem Mol Biol       Date:  2012-09-25

Review 3.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

Review 4.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

5.  Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications.

Authors:  Shuju Wu; Lijie Yu
Journal:  Cytotechnology       Date:  2015-04-23       Impact factor: 2.058

6.  SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.

Authors:  Mingjia Tan; Yongchao Zhao; Sun-Jung Kim; Margaret Liu; Lijun Jia; Thomas L Saunders; Yuan Zhu; Yi Sun
Journal:  Dev Cell       Date:  2011-11-23       Impact factor: 12.270

Review 7.  Biological determinants of radioresistance and their remediation in pancreatic cancer.

Authors:  Parthasarathy Seshacharyulu; Michael J Baine; Joshua J Souchek; Melanie Menning; Sukhwinder Kaur; Ying Yan; Michel M Ouellette; Maneesh Jain; Chi Lin; Surinder K Batra
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-02-27       Impact factor: 10.680

8.  Induction of autophagy and senescence by knockdown of ROC1 E3 ubiquitin ligase to suppress the growth of liver cancer cells.

Authors:  D Yang; L Li; H Liu; L Wu; Z Luo; H Li; S Zheng; H Gao; Y Chu; Y Sun; J Liu; L Jia
Journal:  Cell Death Differ       Date:  2012-08-31       Impact factor: 15.828

9.  Radiosensitization of Cancer Cells by Inactivation of Cullin-RING E3 Ubiquitin Ligases.

Authors:  Dongping Wei; Meredith A Morgan; Yi Sun
Journal:  Transl Oncol       Date:  2012-10-01       Impact factor: 4.243

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.